Accredo Health Group is categorized under Mail Order Pharmaceuticals in Birmingham, AL .
Accredo Health Group was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Barbara Hockaday, Manager at the company’s branch by writing to 2100 Riverchase Center # 405, Birmingham, Alabama AL 35244 or by phoning (205) 987-0778. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Accredo Health Group |
| Contact Person: | Barbara Hockaday, Manager |
| Address: | 2100 Riverchase Center # 405, Birmingham, Alabama 35244 |
| Phone Number: | (205) 987-0778 |
| Website Address: | accredo.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Mail Order Pharmaceuticals |
| SIC Code: | 5961 |
| NAICS Code: | 6219992 |
| Share This Business: |
Accredo Health Group was started in 0 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Barbara Hockaday, Manager for inquiries that concern Accredo Health Group by calling the company number (205) 987-0778, as your correspondence is most welcome. Additionally, the physical location of the branch of Accredo Health Group can be found at the coordinates 33.36494,-86.78712 as well as the street address 2100 Riverchase Center # 405 in Birmingham, Alabama 35244.
For its online presence, you may visit Accredo Health Group’s website at accredo.com and engage with its social media outlets through on Twitter and on Facebook.